Literature DB >> 1547558

Circadian changes in plasma phosphate concentration, urinary phosphate excretion, and cellular phosphate shifts.

G J Kemp1, A Blumsohn, B W Morris.   

Abstract

The concentration of phosphate (Pi) in plasma, Pi excretion, and the tubular threshold of Pi resorption (TmP/GFR) all increase throughout the day from about 1100 to 0300 h. For plasma [Pi], cosinor analysis yielded the following estimates of the parameters of this pattern (with 95% confidence limits): amplitude = 0.17 (0.07-0.26) mmol/L, phase = peak at 0201 (1127-0342) h, and MESOR = 1.14 (1.11-1.18) mmol/L. The increase in TmP/GFR reflects an underlying change in renal Pi handling, which is not attributable to changes in parathyrin concentrations. The changes in Pi excretion work both for and against the changes in plasma [Pi], at different times. The calculated net nonrenal flux of Pi into the extracellular fluid increases in the morning and remains high until 0300 h, and neither it nor Pi excretion nor plasma [Pi] shows any relation to meals. This illustrates the importance of transient net fluxes of Pi between intracellular and extracellular spaces in the control of hour-to-hour changes of plasma [Pi].

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1547558

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  14 in total

1.  Racial differences in postprandial mineral ion handling in health and in chronic kidney disease.

Authors:  Orlando M Gutiérrez; Tamara Isakova; Kelsey Smith; Michael Epstein; Neha Patel; Myles Wolf
Journal:  Nephrol Dial Transplant       Date:  2010-06-07       Impact factor: 5.992

2.  Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study.

Authors:  C P Williams; D F Child; P R Hudson; G K Davies; M G Davies; R John; P S Anandaram; A R De Bolla
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

3.  Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis.

Authors:  Maarten A de Jong; Sergei I Petrykiv; Gozewijn D Laverman; Antonius E van Herwaarden; Dick de Zeeuw; Stephan J L Bakker; Hiddo J L Heerspink; Martin H de Borst
Journal:  Clin J Am Soc Nephrol       Date:  2018-12-17       Impact factor: 8.237

4.  Circadian variation of mineral and bone parameters in end-stage renal disease.

Authors:  Hariprasad Trivedi; Aniko Szabo; Shi Zhao; Tom Cantor; Hershel Raff
Journal:  J Nephrol       Date:  2014-08-20       Impact factor: 3.902

5.  Unchanged expression of the sodium-dependent phosphate cotransporter NaPi-IIa despite diurnal changes in renal phosphate excretion.

Authors:  Bernhard Bielesz; Desa Bacic; Katharina Honegger; Jürg Biber; Heini Murer; Carsten A Wagner
Journal:  Pflugers Arch       Date:  2006-05-19       Impact factor: 3.657

6.  The New Nordic Diet: phosphorus content and absorption.

Authors:  Louise Salomo; Sanne K Poulsen; Marianne Rix; Anne-Lise Kamper; Thomas M Larsen; Arne Astrup
Journal:  Eur J Nutr       Date:  2015-05-08       Impact factor: 5.614

Review 7.  Regulation of phosphate transport in proximal tubules.

Authors:  J Biber; N Hernando; I Forster; H Murer
Journal:  Pflugers Arch       Date:  2008-08-29       Impact factor: 3.657

8.  The reno-pineal axis: A novel role for melatonin.

Authors:  Sanjay Kalra; Swati Agrawal; Manisha Sahay
Journal:  Indian J Endocrinol Metab       Date:  2012-03

9.  Ethnic differences in parathyroid hormone secretion and mineral metabolism in response to oral phosphate administration.

Authors:  Liya Yan; Inez Schoenmakers; Bo Zhou; Landing M Jarjou; Emily Smith; Shailja Nigdikar; Gail R Goldberg; Ann Prentice
Journal:  Bone       Date:  2009-04-24       Impact factor: 4.398

10.  Urinary phosphorus excretion per creatinine clearance as a prognostic marker for progression of chronic kidney disease: a retrospective cohort study.

Authors:  Tomoki Kawasaki; Yoshitaka Maeda; Hisazumi Matsuki; Yuko Matsumoto; Masanobu Akazawa; Tamaki Kuyama
Journal:  BMC Nephrol       Date:  2015-07-28       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.